Biosynex (ALBIO) — Cash Flow Quality Index
Biosynex (ALBIO) has a Cash Flow Quality Index of 0.19x as of June 2022. Operating cash flow of €5.96 Million is below net income of €30.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Biosynex (ALBIO) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biosynex Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Biosynex across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ALBIO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Biosynex (2017–2022)
Year-by-year earnings quality comparison for Biosynex. For live market cap and the full company financial profile, see ALBIO market cap.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.32x | €4.95 Million | €15.61 Million | ▼ -69.2% |
| 2021 | 1.03x | €109.83 Million | €106.68 Million | ▲ +2.1% |
| 2020 | 1.01x | €31.64 Million | €31.37 Million | ▼ -53.2% |
| 2019 | 2.15x | €1.10 Million | €512.31K | ▲ +150.5% |
| 2018 | 0.86x | €467.12K | €542.89K | ▼ -44.1% |
| 2017 | 1.54x | €484.82K | €315.22K | — |